FCSC Insider Trading Activity and SEC Form 4 Filings
FCSC insider trading summary
No open-market insider purchases or sales of Fibrocell Science, Inc. (FCSC) have been reported on SEC Form 4 in the past 12 months.
Latest FCSC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 22, 2018 | John Michael Maslowski | CEO | Buy | $6K (3,000 @ $2.06) |
| Dec 11, 2017 | Randal J Kirk | 10% Owner | Buy | $120K (155,347 @ $0.77) |
| Dec 11, 2017 | Intrexon Corp | 10% Owner | Buy | $2.0M (2,567,121 @ $0.77) |
| Dec 11, 2017 | Randal J Kirk | 10% Owner | Buy | $2.0M (2,567,121 @ $0.77) |
| Dec 11, 2017 | Intrexon Corp | 10% Owner | Buy | $120K (155,347 @ $0.77) |
| Dec 11, 2017 | Randal J Kirk | 10% Owner | Buy | $4K (4,805 @ $0.77) |
| Dec 11, 2017 | Intrexon Corp | 10% Owner | Buy | $4K (4,805 @ $0.77) |
| Dec 2, 2016 | David Pernock | Chairman and CEO | Buy | $46K (50,000 @ $0.92) |
| Nov 13, 2015 | David Pernock | Chairman and CEO | Buy | $15K (3,000 @ $5.00) |
| Aug 11, 2015 | David Pernock | Chairman and CEO | Buy | $23K (3,500 @ $6.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.